Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189995 | SCV000243667 | likely benign | not provided | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000563688 | SCV000675747 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-12 | criteria provided, single submitter | clinical testing | The p.T746I variant (also known as c.2237C>T), located in coding exon 20 of the TSC2 gene, results from a C to T substitution at nucleotide position 2237. The threonine at codon 746 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001086435 | SCV000765873 | benign | Tuberous sclerosis 2 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001086435 | SCV002039629 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001086435 | SCV003821616 | uncertain significance | Tuberous sclerosis 2 | 2022-01-28 | criteria provided, single submitter | clinical testing |